NCT03998449View on ClinicalTrials.gov

Immunogenicity of Cholera Vaccine in Children With IBD

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

April 1, 2020

Study Completion Date

May 1, 2020

Conditions
CholeraInflammatory Bowel Diseases
Interventions
BIOLOGICAL

Vaccination against cholera

Participants will receive two doses of an oral cholera vaccine with an interval of 2-4 weeks.

Trial Locations (1)

02-091

Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

Medical University of Gdansk

OTHER

lead

Medical University of Warsaw

OTHER

NCT03998449 - Immunogenicity of Cholera Vaccine in Children With IBD | Biotech Hunter | Biotech Hunter